» Authors » Mohan Chand Pant

Mohan Chand Pant

Explore the profile of Mohan Chand Pant including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 109
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Painuly N, Singh N, Raj Verma T, Chairmadurai A, Chaudhari L, Saily A, et al.
J Cancer Res Ther . 2016 Feb; 11(4):775-9. PMID: 26881517
Introduction: Accurate dosimetry at the interface of two different density medium (e.g., air cavity in the head and neck cancers and lungs in thoracic region) is a major cause of...
2.
Gupta S, Pant M, Husain N, Sundar S, Khan H
Ear Nose Throat J . 2014 Jan; 93(1):E12-4. PMID: 24452896
Primary mucosal malignant melanomas of the nose are rare, accounting for only 0.3 to 2% of all cases of malignant melanoma and about 4% of all head and neck melanomas....
3.
Shukla P, Gupta D, Pant M, Parmar D
J Cancer Res Ther . 2012 Apr; 8(1):40-5. PMID: 22531512
Aims: A major problem in cancer pharmacology is the unpredictability of the outcome of therapy, both in terms of tumor response and host toxicity. Pharmacogenetic variability associated with the drug...
4.
Kumar A, Pant M, Singh H, Khandelwal S
Tumour Biol . 2011 Nov; 33(1):111-9. PMID: 22081374
Squamous cell carcinoma of head and neck (SCCHN) is the sixth most common cancer globally, and in India, it accounts for 30% of all cancer cases. Epidemiological studies have shown...
5.
Kumar A, Pant M, Singh H, Khandelwal S
Mutat Res . 2011 Oct; 726(2):227-33. PMID: 21986195
Squamous cell carcinoma of head and neck (SCCHN), one of the leading cancers worldwide, is most prevalent in Indian sub-continent. The major risk factors involved are smoking and consumption of...
6.
Kumar A, Pant M, Singh H, Khandelwal S
Mutat Res . 2011 Sep; 729(1-2):24-34. PMID: 21945240
Effective DNA repair machinery ensures maintenance of genomic integrity. Environmental insults, ageing and replication errors necessitate the need for proper DNA repair systems. Any alteration in DNA repair efficacy would...
7.
Shukla P, Gupta D, Bisht S, Pant M, Bhatt M, Srivastava K, et al.
Indian J Med Paediatr Oncol . 2010 Sep; 30(4):124-30. PMID: 20838553
Introduction: Metastatic carcinoma in the lymph nodes of the neck from an unknown primary is relatively rare, accounting for about 3% of all head and neck cancers. Management of secondary...
8.
Shukla P, Gupta D, Bisht S, Pant M, Bhatt M, Gupta R, et al.
Cancer . 2010 Feb; 116(8):2031-5. PMID: 20162717
Background: Mucositis, a radiotherapy-associated toxicity, is an important factor determining morbidity and treatment compliance. Gastrointestinal mucositis in patients undergoing radiotherapy may also depend on time of administration of radiation in...
9.
Goyal M, Shukla P, Gupta D, Bisht S, Dhawan A, Gupta S, et al.
Int J Radiat Biol . 2009 May; 85(6):504-9. PMID: 19412843
Purpose: Patients of head and neck cancer undergoing radiotherapy develop oral mucositis. The severity of mucositis may also depend on the time of administration of radiation apart from patient-related factors....
10.
Gupta D, Shukla P, Bisht S, Dhawan A, Pant M, Bhatt M, et al.
Cancer Biol Ther . 2009 Mar; 8(3):213-7. PMID: 19276670
Purpose: Induction chemotherapy has shown to provide consistent benefit for local control in primary treatment of advanced oropharyngeal cancer. The beneficial role of chemoradiation following induction chemotherapy over concurrent chemoradiation...